"Penka, Miroslav" . . "Kov\u00E1\u0159ov\u00E1, Lucie" . "5"^^ . . "5"^^ . . "Dendritic cells are higly specialized antigen-presenting cells, which can be used for immunotheraphy trials. Functionally normal DCs play a critical role in the activation and potentiation of tumor antigen-specific responses. Under serum free conditions there was no difference in healthy volunteers, MGUS and MM patients, but CD40L stimulation did not lead to the full maturation of DCs. Patients autologous serum had a negative influence on DCs, but it was depending not only on IL-6 level."@en . "Srovn\u00E1n\u00ED vybran\u00FDch marker\u016F dendritick\u00FDch bun\u011Bk u zdrav\u00FDch d\u00E1rc\u016F a\u00A0pacient\u016F s\u00A0monoklon\u00E1ln\u00ED gamapati\u00ED nejasn\u00E9ho v\u00FDznamu \u010Di mnoho\u010Detn\u00FDm myelomem" . "K\u00FDr, Michal" . "Dendritick\u00E9 bu\u0148ky jsou \u00FA\u010Dinn\u00E9 antigen-prezentuj\u00EDc\u00ED bu\u0148ky s\u00A0mo\u017En\u00FDm uplatn\u011Bn\u00EDm na poli imunoterapie, kdy je ov\u0161em z\u00E1sadn\u00ED jejich funk\u010Dn\u00ED stav,tedy schopnost vyvolat protin\u00E1dorovou odpov\u011B\u010F. Kultivace DB v bezs\u00E9rov\u00FDch podm\u00EDnk\u00E1ch m\u00E1 srovnateln\u00E9 v\u00FDsledky u kontrol i pacient\u016F, p\u0159esto\u017Ee stimulace CD40L nesta\u010D\u00ED k pln\u00E9mu vyzr\u00E1n\u00ED DB. P\u0159edb\u011B\u017En\u011B ukazujeme negativn\u00ED p\u016Fsoben\u00ED autologn\u00EDho s\u00E9ra pacient\u016F na expresi vybran\u00FDch marker\u016F, kter\u00E9 nen\u00ED jednozna\u010Dn\u011B z\u00E1visl\u00E9 na hladin\u011B IL-6."@cs . "H\u00E1jek, Roman" . . . "14110" . . . "Mich\u00E1lek, Jaroslav" . . "6"^^ . "Klinick\u00E1 onkologie" . "Srovn\u00E1n\u00ED vybran\u00FDch marker\u016F dendritick\u00FDch bun\u011Bk u zdrav\u00FDch d\u00E1rc\u016F a\u00A0pacient\u016F s\u00A0monoklon\u00E1ln\u00ED gamapati\u00ED nejasn\u00E9ho v\u00FDznamu \u010Di mnoho\u010Detn\u00FDm myelomem" . "dendritic cells; monoclonal gammopathy of undetermined significancy; multiple myeloma; flowcytometry"@en . . "396808" . . "ro\u010D. 21" . . "[659AFC3378E6]" . . . . . "Srovn\u00E1n\u00ED vybran\u00FDch marker\u016F dendritick\u00FDch bun\u011Bk u zdrav\u00FDch d\u00E1rc\u016F a\u00A0pacient\u016F s\u00A0monoklon\u00E1ln\u00ED gamapati\u00ED nejasn\u00E9ho v\u00FDznamu \u010Di mnoho\u010Detn\u00FDm myelomem"@cs . "0862-495X" . "Comparison of DCs antigens in healthy volunteers and monoclonal gammopathy and/or multiple myeloma patients"@en . "Dendritick\u00E9 bu\u0148ky jsou \u00FA\u010Dinn\u00E9 antigen-prezentuj\u00EDc\u00ED bu\u0148ky s\u00A0mo\u017En\u00FDm uplatn\u011Bn\u00EDm na poli imunoterapie, kdy je ov\u0161em z\u00E1sadn\u00ED jejich funk\u010Dn\u00ED stav,tedy schopnost vyvolat protin\u00E1dorovou odpov\u011B\u010F. Kultivace DB v bezs\u00E9rov\u00FDch podm\u00EDnk\u00E1ch m\u00E1 srovnateln\u00E9 v\u00FDsledky u kontrol i pacient\u016F, p\u0159esto\u017Ee stimulace CD40L nesta\u010D\u00ED k pln\u00E9mu vyzr\u00E1n\u00ED DB. P\u0159edb\u011B\u017En\u011B ukazujeme negativn\u00ED p\u016Fsoben\u00ED autologn\u00EDho s\u00E9ra pacient\u016F na expresi vybran\u00FDch marker\u016F, kter\u00E9 nen\u00ED jednozna\u010Dn\u011B z\u00E1visl\u00E9 na hladin\u011B IL-6." . . "Srovn\u00E1n\u00ED vybran\u00FDch marker\u016F dendritick\u00FDch bun\u011Bk u zdrav\u00FDch d\u00E1rc\u016F a\u00A0pacient\u016F s\u00A0monoklon\u00E1ln\u00ED gamapati\u00ED nejasn\u00E9ho v\u00FDznamu \u010Di mnoho\u010Detn\u00FDm myelomem"@cs . "RIV/00216224:14110/08:00025800" . "P(LC06027), P(NR8081)" . . "CZ - \u010Cesk\u00E1 republika" . "RIV/00216224:14110/08:00025800!RIV10-MZ0-14110___" . . "Comparison of DCs antigens in healthy volunteers and monoclonal gammopathy and/or multiple myeloma patients"@en . "1" . . . .